Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
July-2017 Volume 14 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2017 Volume 14 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Role of nuclear factor (erythroid-derived 2)-like 2 in the age-resistant properties of the glaucoma trabecular meshwork

  • Authors:
    • Jintao Cheng
    • Jiamei Liang
    • Jinze Qi
  • View Affiliations / Copyright

    Affiliations: Department of Ophthalmology, Yishui Central Hospital, Linyi, Shandong 276400, P.R. China
  • Pages: 791-796
    |
    Published online on: June 2, 2017
       https://doi.org/10.3892/etm.2017.4543
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Glaucoma is a major cause of irreversible blindness. Nuclear factor (erythroid-derived 2)‑like 2 (Nrf2) regulates the expression of numerous antioxidants within cells and is therefore a focus of current ophthalmic research. To determine the roles of Nrf2 in mediating the glaucoma trabecular meshwork (GTM), the present study evaluated the levels of Nrf2 expression in GTM and human trabecular meshwork (HTM) cells by reverse‑transcription‑quantitative polymerase chain reaction and western blot analysis. It was principally observed that Nrf2 expression was downregulated in GTM cells. In addition, to determine the influence of Nrf2 on the apoptosis and proliferation of GTM and HTM cells, transfection assays and western blotting were performed to evaluate the expression of apoptosis‑related proteins. The results of the current study indicated that Nrf2 may promote viability and reduce apoptosis in GTM and HTM cells. Collectively, these data suggest that Nrf2 may be a novel therapeutic target to treat glaucoma.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Akram MU, Tariq A, Khalid S, Javed MY, Abbas S and Yasin UU: Glaucoma detection using novel opticdisc localization, hybrid feature set and classification techniques. Australas Phys Eng Sci Med. 38:643–655. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Hua Z, Fang Q, Sha X, Yang R and Hong Z: Role of retinal nerve fiber layer thickness and optic disk measurement by OCT on early diagnosis of glaucoma. Eye Sci. 30:7–12. 2015.PubMed/NCBI

3 

Pinchuk L, Riss I, Batlle JF, Kato YP, Martin JB, Arrieta E, Palmberg P, Parrish RK II, Weber BA, Kwon Y and Parel JM: The development of a micro-shunt made from poly (styrene-block-isobutylene-block-styrene) to treat glaucoma. J Biomed Mater Res B Appl Biomater. 105:211–221. 2017. View Article : Google Scholar : PubMed/NCBI

4 

Wilson GN, Inman DM, Denger-Crish CM, Smith MA and Crish SD: Early pro-inflammatory cytokine elevations in the DBA/2J mouse model of glaucoma. J Neuroinflammation. 12:1762015. View Article : Google Scholar : PubMed/NCBI

5 

Nuschke AC, Farrell SR, Levesque JM and Chauhan BC: Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma los. Exp Eye Res. 141:111–124. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Vidal-Sanz M, Salinas-Navarro M, Nadal-Nicolás FM, Alarcón-Martínez L, Valiente-Soriano FJ, De Imperial JM, Avilés-Trigueros M, Agudo-Barriuso M and Villegas-Pérez MP: Understanding glaucomatous damage: Anatomical and functional data from ocular hypertensive rodent retinas. Prog Retin Eye Res. 31:1–27. 2012. View Article : Google Scholar : PubMed/NCBI

7 

Baskaran M, Foo RC, Cheng CY, Narayanaswamy AK, Zheng YF, Wu R, Saw SM, Foster PJ, Wong TY and Aung T: The prevalence and types of glaucoma in an urban Chinese population: The Singapore Chinese eye study. JAMA Ophthalmol. 133:874–880. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Song W, Shan L, Cheng F, Fan P, Zhang L, Qu W, Zhang Q and Yuan H: Prevalence of glaucoma in a rural northern China adult population: A population-based survey in kailu county, inner mongolia. Ophthalmology. 118:1982–1988. 2011. View Article : Google Scholar : PubMed/NCBI

9 

Tham YC, Li X, Wong TY, Quigley HA, Aung T and Cheng CY: Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology. 121:2081–2090. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Wostyn P, van Dam D, Audenaert K, Killer HE, De Deyn PP and De Groot V: A new glaucoma hypothesis: A role of glymphatic system dysfunction. Fluids Barriers CNS. 12:162015. View Article : Google Scholar : PubMed/NCBI

11 

Cuchra M, Markiewicz L, Mucha B, Pytel D, Szymanek K, Szemraj J, Szaflik J, Szaflik JP and Majsterek I: The role of base excision repair in the development of primary open angle glaucoma in the Polish population. Mutat Res. 778:26–40. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Mousa A, Kondkar AA, Al-Obeidan SA, Azad TA, Sultan T, Osman E and Abu-Amero KK: Association of total antioxidants level with glaucoma type and severity. Saudi Med J. 36:671–677. 2015. View Article : Google Scholar : PubMed/NCBI

13 

Almasieh M, Wilson AM, Morquette B, Vargas JL Cueva and Di Polo A: The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res. 31:152–181. 2012. View Article : Google Scholar : PubMed/NCBI

14 

Lebrun-Julien F and Di Polo A: Molecular and cell-based approaches for neuroprotection in glaucoma. Optom Vis Sci. 85:417–424. 2008. View Article : Google Scholar : PubMed/NCBI

15 

Doucette LP, Rasnitsyn A, Seifi M and Walter MA: The interactions of genes, age, and environment in glaucoma pathogenesis. Surv Ophthalmol. 60:310–326. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Liu P, Zhang M, Shoeb M, Hogan D, Tang L, Syed MF, Wang CZ, Campbell GA and Ansari NH: Metal chelator combined with permeability enhancer ameliorates oxidative stress-associated neurodegeneration in rat eyes with elevated intraocular pressure. Free Radic Biol Med. 69:289–299. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Vohra R, Tsai JC and Kolko M: The role of inflammation in the pathogenesis of glaucoma. Surv Ophthalmol. 58:311–320. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Nickells RW, Howell GR, Soto I and John SW: Under pressure: Cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Annu Rev Neurosci. 35:153–179. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Motallebipour M, Rada-Iglesias A, Jansson M and Wadelius C: The promoter of inducible nitric oxide synthase implicated in glaucoma based on genetic analysis and nuclear factor binding. Mol Vis. 11:950–957. 2005.PubMed/NCBI

20 

Itakura T, Peters DM and Fini ME: Glaucomatous MYOC mutations activate the IL-1/NF-κB inflammatory stress response and the glaucoma marker SELE in trabecular meshwork cells. Mol Vis. 21:1071–1084. 2015.PubMed/NCBI

21 

Chen WS, Cao Z, Krishnan C and Panjwani N: Verteporfin without light stimulation inhibits YAP activation in trabecular meshwork cells: Implications for glaucoma treatment. Biochem Biophys Res Commun. 466:221–225. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Pattabiraman PP and Rao PV: Hic-5 regulates actin cytoskeletal reorganization and expression of fibrogenic markers and myocilin intrabecular meshwork cells. Invest Ophthalmol Vis Sci. 56:5656–5669. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Stothert AR, Fontaine SN, Sabbagh JJ and Dickey CA: Targeting the ER-autophagy system in the trabecular meshwork to treat glaucoma. Exp Eye Res. 144:38–45. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Morgan JT, Raghunathan VK, Chang YR, Murphy CJ and Russell P: The intrinsic stiffness of human trabecular meshwork cells increases with senescence. Oncotarget. 6:15362–15374. 2015. View Article : Google Scholar : PubMed/NCBI

25 

Sachdeva MM, Cano M and Handa JT: Nrf2 signaling is impaired in the aging RPE given an oxidative insult. Exp Eye Res. 119:111–114. 2014. View Article : Google Scholar : PubMed/NCBI

26 

Ruiz S, Pergola PE, Zager RA and Vaziri ND: Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 83:1029–1041. 2013. View Article : Google Scholar : PubMed/NCBI

27 

Xu Z, Wei Y, Gong J, Cho H, Park JK, Sung ER, Huang H, Wu L, Eberhart C, Handa JT, et al: Nrf2 plays a protective role in diabetic retinopathy in mice. Diabetologia. 57:204–213. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Ko SY, Chang SS, Lin IH and Chen HI: Suppression of antioxidant Nrf-2 and downstream pathway in H9c2 cells by advanced glycation end products (AGEs) via ERK phosphorylation. Biochimie. 118:8–14. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Njayou FN, Amougou AM, Tsayem R Fouemene, Manjia J Njikam, Rudraiah S, Bradley B, Manautou JE and Fewou Moundipa P: Antioxidant fractions of Khaya grandifoliola C.DC. and Entada africana Guill. et Perr. induce nuclear translocation of Nrf2 in HC-04 cells. Cell Stress Chaperones. 20:991–1000. 2015. View Article : Google Scholar : PubMed/NCBI

30 

Fransson L, Rosengren V, Saha TK, Grankvist N, Islam T, Honkanen RE, Sjöholm Å and Ortsäter H: Mitogen-activated protein kinases and protein phosphatase 5 mediate glucocorticoid-induced cytotoxicity in pancreatic islets and β-cells. Mol Cell Endocrinol. 383:126–136. 2014. View Article : Google Scholar : PubMed/NCBI

31 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

32 

Jung HS, Rajasekaran N, Song SY, Kim YD, Hong S, Choi HJ, Kim YS, Choi JS, Choi YL and Shin YK: Human papillomavirus E6/E7-specific siRNA potentiates the effect of radiotherapy for cervical cancer in vitro and in vivo. Int J Mol Sci. 16:12243–12260. 2015. View Article : Google Scholar : PubMed/NCBI

33 

Qin YU, Wang H, Liu ZY, Liu J and Wu JZ: Realgar quantum dots induce apoptosis and necrosis in HepG2 cells through endoplasmic reticulum stress. Biomed Rep. 3:657–662. 2015.PubMed/NCBI

34 

Lee JY, Jee SB, Park WY, Choi YJ, Kim B and Kim YH, Jun do Y and Kim YH: Tumor suppressor protein p53 promotes 2-methoxyestradiol-induced activation of Bak and Bax, leading to mitochondria-dependent apoptosis in human colon cancer HCT116 cells. J Microbiol Biotechnol. 24:1654–1663. 2014. View Article : Google Scholar : PubMed/NCBI

35 

Wordinger RJ, Sharma T and Clark AF: The role of TGF-β2 and bone morphogenetic proteins in the trabecular meshwork and glaucoma. J Ocul Pharmacol Ther. 30:154–162. 2014. View Article : Google Scholar : PubMed/NCBI

36 

Chen X, Xu Y, Duan L, Zhang Z, Wong DWK and Liu J: Multiple ocular diseases detection by graph regularized multi-label learning. 2014.

37 

Casson RJ, Chidlow G, Ebneter A, Wood JP, Crowston J and Goldberg I: Translational neuroprotection research in glaucoma: A review of definitions and principles. Clin Exp Ophthalmol. 40:350–357. 2012. View Article : Google Scholar : PubMed/NCBI

38 

Janulevičiene I, Ehrlich R, Siesky B, Nedzelskienė I and Harris A: Evaluation of hemodynamic parameters as predictors of glaucoma progression. J Ophthalmol. 2011:1643202011. View Article : Google Scholar : PubMed/NCBI

39 

Crabb JW, Yuan X, Crabb JS, Putliwala TM, Clark AF and Bollinger KE: Quantitative proteomic studies implicate mitochondrial dysfunction in the trabecular meshwork in glaucoma pathology. 2011.

40 

Tamm ER, Braunger BM and Fuchshofer R: Intraocular pressure and the mechanisms involved in resistance of the aqueous humor flow in the trabecular meshwork outflow pathways. Prog Mol Biol Transl Sci. 134:301–314. 2015. View Article : Google Scholar : PubMed/NCBI

41 

Zheng H, Nong Z and Lu G: Correlation between nuclear factor E2-related factor 2 expression and gastric cancer progression. Med Sci Monit. 21:2893–2899. 2015. View Article : Google Scholar : PubMed/NCBI

42 

Leone A, Roca MS, Ciardiello C, Terranova-Barberio M, Vitagliano C, Ciliberto G, Mancini R, Di Gennaro E, Bruzzese F and Budillon A: Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway. Free Radic Biol Med. 89:287–299. 2015. View Article : Google Scholar : PubMed/NCBI

43 

Wang D, Ma Y, Yang X, Xu X, Zhao Y, Zhu Z, Wang X, Deng H, Li C, Gao F, et al: Hypermethylation of the Keap1 gene inactivates its function, promotes Nrf2 nuclear accumulation, and is involved in arsenite-induced human keratinocyte transformation. Free Radic Biol Med. 89:209–219. 2015. View Article : Google Scholar : PubMed/NCBI

44 

Rushworth SA, Bowles KM and MacEwan DJ: High basal nuclear levels of Nrf2 in acute myeloid leukemia reduces sensitivity to proteasome inhibitors. Cancer Res. 71:1999–2009. 2011. View Article : Google Scholar : PubMed/NCBI

45 

Ohnuma T, Anzai E, Suzuki Y, Shimoda M, Saito S, Nishiyama T, Ogura K and Hiratsuka A: Selective antagonization of activated Nrf2 and inhibition of cancer cell proliferation by procyanidins from Cinnamomi Cortex extract. Arch Biochem Biophys. 585:17–24. 2015. View Article : Google Scholar : PubMed/NCBI

46 

Pastorek M, Müller P and Vojtěšek B: Nrf2- two faces of antioxidant system regulation. Klin Onkol. 28 Suppl 2:2S26–2S31. 2015.(In Czech). View Article : Google Scholar : PubMed/NCBI

47 

Tertil M, Golda S, Skrzypek K, Florczyk U, Weglarczyk K, Kotlinowski J, Maleszewska M, Czauderna S, Pichon C, Kieda C, et al: Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: Antitumoral effects associated with down-regulation of matrix metalloproteinases. Free Radic Biol Med. 89:147–157. 2015. View Article : Google Scholar : PubMed/NCBI

48 

Ran W, Zhu D and Feng Q: TGF-β2 stimulates Tenon's capsule fibroblast proliferation in patients with glaucoma via suppression of miR-29b expression regulated by Nrf2. Int J Clin Exp Pathol. 8:4799–4806. 2015.PubMed/NCBI

49 

Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R and Tang D: Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 63:173–184. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Cheng J, Liang J and Qi J: Role of nuclear factor (erythroid-derived 2)-like 2 in the age-resistant properties of the glaucoma trabecular meshwork. Exp Ther Med 14: 791-796, 2017.
APA
Cheng, J., Liang, J., & Qi, J. (2017). Role of nuclear factor (erythroid-derived 2)-like 2 in the age-resistant properties of the glaucoma trabecular meshwork. Experimental and Therapeutic Medicine, 14, 791-796. https://doi.org/10.3892/etm.2017.4543
MLA
Cheng, J., Liang, J., Qi, J."Role of nuclear factor (erythroid-derived 2)-like 2 in the age-resistant properties of the glaucoma trabecular meshwork". Experimental and Therapeutic Medicine 14.1 (2017): 791-796.
Chicago
Cheng, J., Liang, J., Qi, J."Role of nuclear factor (erythroid-derived 2)-like 2 in the age-resistant properties of the glaucoma trabecular meshwork". Experimental and Therapeutic Medicine 14, no. 1 (2017): 791-796. https://doi.org/10.3892/etm.2017.4543
Copy and paste a formatted citation
x
Spandidos Publications style
Cheng J, Liang J and Qi J: Role of nuclear factor (erythroid-derived 2)-like 2 in the age-resistant properties of the glaucoma trabecular meshwork. Exp Ther Med 14: 791-796, 2017.
APA
Cheng, J., Liang, J., & Qi, J. (2017). Role of nuclear factor (erythroid-derived 2)-like 2 in the age-resistant properties of the glaucoma trabecular meshwork. Experimental and Therapeutic Medicine, 14, 791-796. https://doi.org/10.3892/etm.2017.4543
MLA
Cheng, J., Liang, J., Qi, J."Role of nuclear factor (erythroid-derived 2)-like 2 in the age-resistant properties of the glaucoma trabecular meshwork". Experimental and Therapeutic Medicine 14.1 (2017): 791-796.
Chicago
Cheng, J., Liang, J., Qi, J."Role of nuclear factor (erythroid-derived 2)-like 2 in the age-resistant properties of the glaucoma trabecular meshwork". Experimental and Therapeutic Medicine 14, no. 1 (2017): 791-796. https://doi.org/10.3892/etm.2017.4543
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team